MAPT and Alzheimer disease: These plaques are believed to contribute to the neurodegeneration seen in AD by inducing neuroinflammation, disrupting synaptic function, and promoting the aggregation of tau protein, another key pathological feature of AD (Jeremic, Jiménez‐Díaz, and Navarro‐López 2021).